RxDoctor Payments Data

Katherine Gambill

Family · Las Vegas, NVNPI 1215681127

Payments from drug & device makers

$4,157in general payments, 2019–2025

Across 169 payments — averaging $24.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$534
  • AstraZeneca$483
  • Exact Sciences$318
  • ANI Pharmaceuticals, Inc.$226
  • Astellas Pharma US Inc$158
  • plus $1K from 22 others

What the payments were for

  • Food & beverage$4,141100%
  • Entertainment$160%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,157 in reported general payments places this provider in the 90th percentile of 1,501 family providers in Nevada.

See all family providers in Nevada

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium23$206
Levothyroxine Sodium13$158
Amlodipine Besylate19$134
Lisinopril15$117
Alprazolam11$23

Paid to pharmacies, not to this prescriber.

Other family in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →